These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33250373)

  • 1. HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review.
    Kruijt N; van den Bersselaar LR; Wijma J; Verbeeck W; Coenen MJH; Neville J; Snoeck M; Kamsteeg EJ; Jungbluth H; Kramers C; Voermans NC
    Neuromuscul Disord; 2020 Dec; 30(12):949-958. PubMed ID: 33250373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
    Kruijt N; den Bersselaar LV; Snoeck M; Kramers K; Riazi S; Bongers C; Treves S; Jungbluth H; Voermans N
    Curr Pharm Des; 2022; 28(1):2-14. PubMed ID: 34348614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility.
    Sambuughin N; Capacchione J; Blokhin A; Bayarsaikhan M; Bina S; Muldoon S
    Clin Genet; 2009 Dec; 76(6):564-8. PubMed ID: 19807743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome.
    Witting N; Laforêt P; Voermans NC; Roux-Buisson N; Bompaire F; Rendu J; Duno M; Feillet F; Kamsteeg EJ; Poulsen NS; Dahlqvist JR; Romero NB; Fauré J; Vissing J; Behin A
    Acta Neurol Scand; 2018 May; 137(5):452-461. PubMed ID: 29635721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
    Kraeva N; Sapa A; Dowling JJ; Riazi S
    Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
    Russell T; Riazi S; Kraeva N; Steel AC; Hawryluck LA
    Anaesthesia; 2012 Sep; 67(9):1021-4. PubMed ID: 22734812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between the neuroleptic malignant syndrome and mutations in the RYR1 gene associated malignant hyperthermia.
    Miyatake R; Iwahashi K; Matsushita M; Nakamura K; Suwaki H
    J Neurol Sci; 1996 Nov; 143(1-2):161-5. PubMed ID: 8981316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.
    Dlamini N; Voermans NC; Lillis S; Stewart K; Kamsteeg EJ; Drost G; Quinlivan R; Snoeck M; Norwood F; Radunovic A; Straub V; Roberts M; Vrancken AF; van der Pol WL; de Coo RI; Manzur AY; Yau S; Abbs S; King A; Lammens M; Hopkins PM; Mohammed S; Treves S; Muntoni F; Wraige E; Davis MR; van Engelen B; Jungbluth H
    Neuromuscul Disord; 2013 Jul; 23(7):540-8. PubMed ID: 23628358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees.
    Davis M; Brown R; Dickson A; Horton H; James D; Laing N; Marston R; Norgate M; Perlman D; Pollock N; Stowell K
    Br J Anaesth; 2002 Apr; 88(4):508-15. PubMed ID: 12066726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.
    Voermans NC; Snoeck M; Jungbluth H
    Rev Neurol (Paris); 2016 Oct; 172(10):546-558. PubMed ID: 27663056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome and serotonin syndrome in a female patient: a clinicopathologic case.
    Gómez-Esteban JC; Barcena J; Forcadas M; Somme J; Agundez M; Tijero B; Zarranz JJ
    Clin Neuropharmacol; 2009; 32(5):299-300. PubMed ID: 19820435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome.
    Bertorini TE
    Neurol Clin; 1997 Aug; 15(3):649-71. PubMed ID: 9227957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing to Diagnose Muscular Dystrophy, Rhabdomyolysis, and HyperCKemia.
    Wu L; Brady L; Shoffner J; Tarnopolsky MA
    Can J Neurol Sci; 2018 May; 45(3):262-268. PubMed ID: 29382405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
    Silva HC; Bahia VS; Oliveira RA; Marchiori PE; Scaff M; Tsanaclis AM
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):713-9. PubMed ID: 10973114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Referral Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing.
    van den Bersselaar LR; Hellblom A; Gashi M; Kamsteeg EJ; Voermans NC; Jungbluth H; de Puydt J; Heytens L; Riazi S; Snoeck MMJ
    Anesthesiology; 2022 Jun; 136(6):940-953. PubMed ID: 35285867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fever-induced recurrent rhabdomyolysis due to a novel mutation in the ryanodine receptor type 1 gene.
    Molenaar JP; Voermans NC; van Hoeve BJ; Kamsteeg EJ; Kluijtmans LA; Kusters B; Jungbluth HJ; van Engelen BG
    Intern Med J; 2014 Aug; 44(8):819-20. PubMed ID: 25081049
    [No Abstract]   [Full Text] [Related]  

  • 18. Electroconvulsive in a Schizophrenic Patient With Neuroleptic Malignant Syndrome and Rhabdomyolysis.
    San Gabriel MC; Eddula-Changala B; Tan Y; Longshore CT
    J ECT; 2015 Sep; 31(3):197-200. PubMed ID: 25243752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families.
    Hermesh H; Aizenberg D; Lapidot M; Munitz H
    Am J Psychiatry; 1988 Nov; 145(11):1431-4. PubMed ID: 3189603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome.
    Sato T; Nishio H; Iwata M; Kentotsuboi ; Tamura A; Miyazaki T; Suzuki K
    Forensic Sci Int; 2010 Jan; 194(1-3):77-9. PubMed ID: 19931341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.